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ABSTRACT
Co-infections occur when hosts are infected by two or more pathogens, either simultaneous or as a
secondary infection. This research aimed to determine the best compositions of vaccine combinations and
their protective efficacies against pathogens co-infection. This research was conducted in two stages.
Firstly, surveys were conducted in three research areas: infected, high risk of infection, and virus free
areas. Samples (three to five fish per pool) were collected from three fish farms per area. The basic antibody
titer of fish from each farm was checked before and after vaccination as well as after the virus challenge in
combination with the PCR result. The second stage of the research was conducted in the laboratory. Carp
and koi fish were used to determine optimal vaccine combination and dosage for oral application. The
results of this research showed that combination of KHV: Aeromonas hydrophila vaccines in the ratio of 1:2
and vaccine volume of 3 mL via the oral application gave higher titer antibody and efficacy against KHV and
A. hydrophila. In conclusion, the combined vaccine offers an effective means of preventing the diseases,
decreasing fish mortality, and simplifying the immunization schedule, which will eventually increase the
overall health of farmed fish and benefit fish farmers and service extension officers. This research
recommends that further development of the combined vaccines should be carried out, for example,
overcoming the technical difficulties in its manufacturing.
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INTRODUCTION
Common carp (Cyprinus carpio L.) is the most
widely farmed fish for human consumption, mainly in
Asia and Europe. On the contrary, koi (C. carpio koi)
are reared primarily as an ornamental fish or compe-
tition events especially in Indonesia and Japan. Inten-
sive culture of common carp and large-scale market
distribution of live koi, often lacking health certifica-
tions, have contributed to the global spread of KHV
disease (KHVD) which responsible for mass mortali-
ties of carp related fish (Haenen et al., 2004).
In Indonesia, the first outbreak of KHVD was re-
ported in East Java in 2002 (Sunarto et al., 2002). Since
then, it has spread rapidly throughout Java Island, Bali,
Southern part of Sumatra, East Kalimantan, and Cen-
tral Sulawesi. The KHVD caused high mortality (80%-
95%) to koi and common carp with estimated eco-
nomic losses up to US$15M in 2003 (Sunarto &
Cameron, 2005).
Co-infection occurs when hosts are infected by
two or more different pathogens, either simultaneous
or as a secondary infection meaning that two or
more infectious agents were present in the same
host (Kotob et al., 2016). During episodes of co-in-
fection, the interactions between the infectious
agents yield to synergism or antagonism conditions:
concentration of one or both pathogens may be in-
creased or suppressed, and one pathogen may be
increased, but the other did not appear (Cox, 2001).
Natural co-infection between Aeromonas veronii and
Tilapia Lake Virus (TiLV) were found as A. veronii
concurrently isolated with TiLV from the diseased
tilapia (Nicholson et al., 2017). According to
Surachetpong et al. (2017), multiple bacteria infec-
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tion, including Flavobacterium, Streptococcus, and
Aeromonas were also found in TiLV infected fish. In-
teractions of A. veronii and TiLV might be synergis-
tic, resulted in enhanced of pathogens infection and
increased severity of the disease. In KHV infection,
the presence of other pathogen such as Aeromonas
hydrophila are relatively common, which induced
higher mortality. Aeromonas spp. commonly associa-
ted with other diseases in warm water fish. It is found
in almost all freshwater environments, sediment, do-
mestic tap water, sewage, and part of normal flora on
the skin.
Fish mortality caused by KHV infection ranged up
to 60% with predominantly marketable-size fish were
affected. Infected fish exhibiting clinical signs with
typical systemic bacterial infection. Aeromonas
hydrophila infection occurs secondarily to preexist-
ing diseases, weakened immune system, injury or
ulcer or following periods of low oxygen, high ammo-
nia, extreme temperature, or other forms of stress
(crowding). Diseased fish are often additionally in-
fected with other bacteria such as Flavobacterium
columnare and Edwardsiella ictaluri (Lusiastuti et al.,
2012). Based on the report of Schmid et al. (2016)
who investigated the efficacy of three inactivated KHV
antigens in common carp, we constructed a combined
vaccine of KHV and A. hydrophila. The attenuated KHV
and its potential use as a vaccine candidate have been
described in the International Patent WO 2004/061093
AI. However, this combined vaccine candidate hides
a potential danger. Viral attenuation as a consequence
of random mutations that occurred during viral repli-
cation in vitro via serial passage in cell culture. Con-
sequently, the character of the attenuation is largely
unknown and reversion to a pathogenic phenotype
cannot be excluded in some circumstances.
Combination vaccines that protect against diffe-
rent infectious diseases can help to simplify the cur-
rent immunization schedule. The other benefits of
combination vaccines include decreased number of
potentially harmfull procedures such as handling and
injection which is more convenience for fish and also
reduced vaccination costs for fish farmers. Other
benefits of using combination vaccines are decreased
infection risk from site of vaccine injection and po-
tentially improved fish health record and tracking. The
benefit of using a combination vaccine in fish health
management will significantly reduce the overall cost
of production associated with fewer vaccination pro-
cess. For example, by using a combination vaccine,
fish are only vaccinated once instead of twice or more
by conventional vaccines. The combination of two
different antigens at the same time will result in diffe-
rences in antigen processing which activate different
signaling pathways by affecting the T-immune cell
response. Hopefully, the combinnation vaccine be-
tween KHV and A. hydrophila can induce a stronger
and protective antibody response. According to
Monaghan et al. (2016), a combination vaccine of
Chlamydia suis and C. trachomatis simultaneously
delivered antigens which improved the immunoge-
nicity and the protective efficacy in pigs. Moreover,
the combination vaccine can potentiate and broaden
pig’s immune response. The aim of this research was
to established the best composition and dosage of
the combination vaccine, and its efficacy for protec-
tion against A. hydrophila and koiherpes virus.
MATERIALS AND METHODS
Fish and Fish Samples
 This research was conducted in two stages. Firstly,
surveys were done in the field by dividing the sam-
pling area into three locations: infected, a high
risk of infection, and virus free areas. The sur-
veys were conducted in Citayam as the infected
area, Ciganjur as the high-risk area and Ciseeng
as the virus free area. The samples were taken
before vaccination, after vaccination and during
challenge tests. Fish were brought to the wet lab
in Depok for challenge test. Samples (three to five
fish per pool) were collected from the three fish
farms in each area. The antibody titer of fish from
each farm was checked before vaccination, after
vaccination and after challenge test with koiherpes
virus in combination with the results of PCR analy-
sis  (Bergmann et al., 2006).
 The second stage of the research was conducted
in the laboratory. In total, 2,000 carp and koi, res-
pectively; were used in the experiment. As much
as 1,000 carps were used to obtain the best com-
bination of the vaccine; and 1,000 koi were used
to find the best dosage for oral application. Pre-
vaccinated fish were taken randomly and tested
for KHV free by PCR analysis (Yuasa et al., 2005)
to ensure the absence of the virus.
 Koi with an initial weight of 10 g, and carp with
an initial length of 5-7 cm were obtained from a
local farm in Depok (West Java) and were used in
the experiment. They were kept in a 2 m x 2 m
concrete pond. A commercial feed with crude pro-
tein content adjusted for fish weight was supplied
ad libitum twice a day (morning and afternoon).
Vaccines Preparation
 Vaccines used in this study were: (1) heat inacti-
vated KHV isolate BJMN-2, and (2) formalin inacti-
vated bacterium A. hydrophila isolate AHL0905-2.
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These bacterial and virus isolates were part of the
collections of the Research Institute for Freshwa-
ter Aquaculture and Fisheries Extension Bogor In-
donesia obtained from natural disease outbreaks.
Both isolates were used for the challenge test.
Preparation for virus inactivation was performed
according to the methods of Nakajima et al. (1999)
and Yasumoto et al. (2006) with slight modifica-
tions.
 Supernatant homogenate were obtained from
tissues of KHV infected fish. One gram of gills,
kidneys and spleen tissues (3:1:1 weight/weight)
were homogenized and then mixed with sterile
PBS until it reached 50x dilution. After that, the
suspension was centrifuged at 15,000 rpm at 4°C
for 15 minute and filtrated through 0.45 m filter
(MF-MilliporeTM). Supernatant homogenate was in-
oculated into koi fin-1 cell (KF-1 cells) in 2%
Leibovits-15 medium for one hour at 25°C for vi-
rus absorption. The virus was then ready to be
harvested when the cytopathic effect had reached
approximately 80%. The cells and medium contain-
ing virus were poured into a 500 mL schott bottle
and ready for the vaccine preparation by heat-in-
activated at 60°C for four hours then it was kept
at 86°C until used (Bergmann et al., 2017).
Determination of 50% tissue culture infective dose
(TCID
50
) was performed using a 96-well microwell
flask. The calculation of TCID
50
 was based on the
Reed & Muench method (1938): TCID50 = (50%-%
positive dilution below 50%) / (% positive dilution
above 50%-% positive under 50%).
 A. hydrophila vaccine preparation was performed
as follows: the bacteria were characterized and
fulfilled the Koch’s Postulates. Pure bacteria were
used as the vaccine seed. The vaccine was pro-
duced using the commercial tryptic soy agar (TSA)
(Merck, Germany) sterile which was poured into
10 cm petridishes. A total of 0.2 mL of bacterial
suspension with a density of 1011 cfu/mL were
transferred onto the surface of agar plates using
L-glass. Incubation was carried out for 24 hours
at a temperature of 27 ± 1°C. Harvesting was
performed by dry system, using disposable ose,
and bacterial growth (grazing rate) with efficiency
above 99%. Inactivation process for vaccine prepa-
ration was carried out by formalin-inactivation
using 1% formaldehyde solution (Merck, Germany)
stirred with magnetic stirrer for two hours. Then,
vaccine stock solution was kept at 4°C-8°C for
24-28 hours. The bacteria harvested from the
three petri dishes was dissolved in 100 mL of
0.85% phosphate buffer saline (Merck, Germany)
and bacterial concentration was 1011 cfu/mL. The
whole process of vaccine preparation was done
aseptically in accordance to Good Laboratory Prac-
tices (GLP).
Each treatment was proceeded with 200 fish with
four replication (50 fish per aquaria)
Treatment 1:
Vaccination was conducted by immersion with a
dose of 10 mL liter-1. Carp (n=10) were immersed
in the suspension.
The vaccination was carried out of five treated
and untreated groups:
A : proportional combination vaccine (1a:1b, v/
v), and challenge test
B : non-proportional combination vaccine (1a:2b,
v/v), and challenge test
C : non-proportional combination vaccine (2a:1b,
v/v), and challenge test
D : no vaccination (negative control), without
challenge test
E : no vaccination (positive control), PBS injec
tion, and challenge test
Treatment 2:
The best in vaccine from treatment-1 was used in
treatment-2 with oral application. The five groups
were treated with:
A : vaccine dose 1 mL kg-1 food, and challenge
test
B : vaccine dose 2 mL kg-1 food, and challenge
test
C : vaccine dose 3 mL kg-1 food, and challenge
test
D : no vaccination (negative control), without
challenge test
E : no vaccination (positive control), PBS injec
tion, and challenge test
KHV and A. hydrophila challenge tests were per-
formed on day 21st and 35th post vaccination. The
KHV challenge test was performed by cohabita-
tion, using KHV infected fish which was previously
injected intraperitoneally with 0.2 mL  fish-1 KHV
and A. hydrophila challenge test was carried out
by intraperitonial injection with 108 CFU mL-1 of
A. hydrophila.
The Evaluation of Test Parameter:
The evaluation based on antibody titer were con-
ducted by direct agglutination assay for A.
hydrophila and enzyme linked immune sorbent
assay (ELISA) for KHV (Bergmann et al., 2017).
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Determination of The Antibody Titer:
After 2nd and 3th weeks post-vaccination and 5th
and 6th weeks after-challenge test, 15 fish from
each group were anaesthetized for blood sampling.
After whole blood phagocytosis index were mea-
sured, plasma was separated and stored at -20°C
until used for ELISA and direct agglutination as-
says.
 The direct agglutination assay was performed to
detect antibody level against A. hydrophila. The
procedure proposed by Roberson (1990) measured
the  antibody level at 2nd and 3th weeks post-vacci-
nation and continued at 5th and 6th weeks after
challenge test. ELISA assay was employed to con-
firm the levels of specific antibodies against KHV
in all serum samples. Phagocytosis index (IF) was
evaluated by using the method of Zhang et al.
(2008) with slight modification.
Data Analysis
The result of phagocytosis index and antibody ti-
ter from survey were analyzed descriptively.
RESULTS AND DISCUSSION
The fish sera from each farm were checked and
monitored by using ELISA assay before vaccination
(Table 1). In Table 1, the infected area was classified
into two separate fish groups, where group-I showed
50% morbidity and group-II showing no morbidity. In
group-I, the antibody titer value was approximately
1:600 and 20% of positive by PCR assay. The mild or
late infection with no clinical signs area, the value of
antibody titers were 1:300 with KHV detection of
40% by PCR assay.
Despite fish group-II and III being in the areas
close to the infected area, none of the samples was
KHV-positive by PCR assay, the antibody titers in the
mild or late infections were 1:300 and PCR assay gave
positive signals in 10% of the samples. No KHV was
detected in 90% of the fish samples by using PCR.
The areas categorized as no KHV infection (clean area)
had 100% negative test results, both using ELISA and
PCR assay.
Table 2 shows that no significant difference be-
tween the antibody titer in mild or late infection fish
and the virus-negative fish in group-I, nor it was
possible, by their antibody titer, to differentiate bet-
ween those fish which had undergone clinical dise-
ase and those which had a persistent or latent infec-
tion. Table 2 showsd that the antibody titer after
vaccination and challenge test was higher compared
to prior  vaccination.
Figure 2 shows the antibody titers after vaccina-
tion compared with the negative controls. Vaccine B,
which consisted of one part of KHV vaccine and two
parts of A. hydrophila vaccine gave a higher antibody
titer in the first week post-vaccination. The assays
showed an increase in antibody titers at the first
month post-vaccination and a decrease at the second
months.
Before and after KHV-Aero vaccination, the
vaccine dose of 3 mL had increased the antibody ti-
ter higher than the other treatments until the 3th week
and then decreased at the 4th week.
The KHV challenge test was performed at 5th week
post-vaccination (Figure 4), which caused the in-
creased in antibody titer of fish group with 3 mL vo-
Table 1. KHV antibody titers and virus detection by using PCR assay from groups of fish in in-
fected and non-infected fish farms before vaccination
Severe infection
(positive PCR) 





Group-I: 50% morbidity (Citayam II, Bogor) 1:600 (20) 1:300 (40) 1:300 (40)
Group-II: 0% morbidity (Citayam I, Depok) 0 1:300 (20) 1:300 (80)
High risk area:
Group-III (Ciganjur) 0 1:300 (10) 0 (90)
Virus free area:
Group-IV (Ciseeng) 0 0 0 (100)
Area
Antibody titers value (PCR detection %)
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Table 2. The mean of KHV antibody titers and PCR detection of KHV from fish groups with and
without infection after vaccination and challenge test
Remarks: 1) marker 100 bp (Promega); sample 2-8) KHV positive; sample 9-13) KHV negative; 14) negative
control; 15) positive control
Severe infection
(positive PCR) 





Group-I: 50% morbidity (Citayam II, Bogor) 0 1:1,200 (60) 1:600 (40)
Group-II: 0% morbidity (Citayam I, Depok) 0 1:600 (60) 1:600 (40)
High risk area:
Group-III (Ciganjur) 0 1:600 (10) 1:1,200 (90)
Virus free area:
Group-IV (Ciseeng) 0 1:300 (10) 1:1,200 (90)
Area
Antibody titers (PCR detection %)
Figure 1. KHV detection by PCR.
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  290 bp 
Figure 2. Antibody titer after vaccination at first month (M1) and 2nd month
(M2) post-vaccination (n=60) with different compositions of the
KHV-Aero vaccine.
Remarks: Vaccine A (1:1); vaccine B (1:2), vaccine C (2:1); D (control negative); E (control
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lume-dosage at 6th week and decreased in antibody
level at 7th week post-vaccination. Surprisingly, after
challenge test with A. hydrophila, antibody titers
against KHV increased again at 8th week post-vacci-
nation. This result is  in accordance with Monaghan
et al. (2016) that a combination vaccine can potenti-
ate the immune response to A. hydrophila  and in-
duce a stronger anti-KHV antibody level.
Figure 5 shows phagocytosis index between the
vaccinated and non-vaccinated groups. In vaccinated
fish, the phagocytosis indexes tend to be lower than
in non-vaccinated fish.
Koiherpes virus (KHV) is a latent or persistent in-
fection, but in a population of fish that has never
been infected, it can cause acute disease with more
than 90% mortality in carp and koi, both seed and
adult (van Regenmortel et al., 2000). In aquatic envi-
ronment, fish were exposed to infectious mixed
pathogens of macro or micro-organisms. There is a
greater risk of mass mortality if a fish population is
infected by either a single or multiple pathogens.  It
is currently unknown whether the presence of a
pathogen is a burden to other pathogens or the mor-
tality rate of the host is increased in coinfection com-
Figure 3. Antibody titer before and after KHV-Aero vaccination (treatment-2,
oral vaccination).
Figure 4. Antibody titers against KHV and A. hydrophila after KHV and
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pared with a single infection (Bradley & Jackson, 2008).
Coinfection models need to be studied in order to
design disease control strategies, especially effective
vaccine designs (Lello et al., 2004).
The onset of antibody titer with KHV: A.
hydrophila 1:2 resulted a higher titer than 1:1 and 2:1
of the vaccine composition. There was a synergistic
interaction between both antigens. A. hydrophila as
an antigen could improved immunogenicity and pro-
tective efficacy against both of KHV and A. hydrophila.
This means that this combination vaccine may po-
tentiate and broaden the immune response. During
co-infections, pathogens can compete with each other
for food resources or target infection sites in the
same host. Pathogen can alter the immune response
of the host against subsequent infections by other
pathogens either by suppressing or boosting the
immune system (Lello et al., 2004, Telfer et al., 2008).
In this research, A. hydrophila acted as a boosting
agent for KHV and developed synergistic effect to
induce the immune system and increasing the anti-
body titer. A. hydrophila as a secondary pathogen trig-
gers and modulates the host immune response in a
positive sense for KHV. This also means that the bac-
terial infection had reactivated persistent KHV which
led to a very fast occurring immune response of anti-
bodies measurable by ELISA assay.
The results presented in Table 2 showed that 40%
immunized fish in group-1 and II had developed a
sufficient immunity to protect themselves against
KHV. However, all of the fish (100%) had become KHV
carriers. Protection against KHV seems to be associ-
ated with elevation of specific antibodies against the
virus. According to Ronen et al. (2003), KHV specific
antibody titer increased at 7th days post-infection (dpi)
and reached its peaks at 21st dpi. The levels of anti-
KHV antibodies remained high in the vaccine injected
group for a period of 1.5-2 months, after which there
was an apparent gradual decline in antibody titer. In
total, 100% of the immunized fish were protected
against the challenged test suggest the presence of
specific efficient memory cells. According to
Perelberg et al. (2008), KHV can remain latent for a
long periods of time inside the infected host, at least
35 weeks post infection. The persistent KHV in the
host can be reactivated through temperature changes,
e.g. non-permissive to a permissive level of water
temperature. Thus, survived fish carrying KHV might
serve as the KHV reservoir.
The immunity of fish in group-III and IV are indi-
cated by the emergence of higher antibody titers than
KHV negative and KHV carrier fish. The most signifi-
cant result was that vaccinated fish which undergo
challenged test showed no symptoms of the disease.
The results showed that vaccination before fish were
infected with KHV had little effect on carrier fish.
Repeated samplings of vaccinated fish failed to re-
veal the condition of the carrier fish. This might in-
dicate that fish which survive a natural outbreak of a
wild type KHV can become carriers and spread the
virus to vaccinated populations. If the fish are kept
at low temperatures or exposed to temperature
stress, it can induce the emergence of the disease
again. Bergmann et al. (2004) and Eide et al. (2011)
showed that virus in latent conditions can be indi-
cated by the presence of latency in fish leukocytes
that have been exposed to KHV. Eide et al. (2011) and
Hilaire et al. (2005),who studied fish with this nature
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latency, found that the infected population was very
small and the concentration of KHV was very low,
only 1-5 virus particles were detected by PCR assay.
Furthermore, Bergmann et al. (2011) stated that to
be able to detect the carrier fish, the virus must be
reactivated using temperature stress. Reactivation of
the virus to a detected level could be less 3-4 days
after going through stress inductions such as tem-
perature, stocking density and feed as these treat-
ments induce hormonal changes in fish. Eide et al.
(2011) also stated that low temperature is one of the
effective ways of reactivating viruses.
Vaccination plays a role in forming immunological
memory which offer a long-term protection. In salmo-
nids, according to McHeyzer-Williams et al. (1999),
there is a response from memory B cells that is lower
than in mammals. Furthermore, according to Ma et
al. (2013), the thymus organ contributes to a loga-
rithmic increase in antibody titers if the re-infection
occcurs. However, revaccination (booster) increases
the antibody titer arithmetically compared with the
first immunization. The results of this study are in
accordance with that of O’Connor et al. (2004) and
Manz et al. (1998) were the diversity and duration of
the limited KHV antibody response after vaccination
may be caused by physiological conditions of fish
which are not as advance as in mammals and the in-
ternal environment of the body related to chemokines,
cytokines, and cell-to-cell interaction in the kidney
anterior. Therefore, revaccination is necessary, so if
an outbreak re-occurs, the vaccines will trigger the
formation of logarithmic antibodies.
Vaccination programs must be carried out com-
prehensively to prevent outbreaks of infectious dis-
eases. Vaccination needs to be done at the right time
to maintain protective conditions starting from the
initial maintenance until fish are harvested. This strat-
egy can help fish farmers to maintain the fish’s health
and thus increase their production. Some notable
immunologic differences exist among the presently
available single-disease vaccines and a cocktail vac-
cine. Using a single vaccine induces earlier immune
response after the first dose. Contrastingly, a combi-
nation vaccine gives higher antibody levels after the
second and third doses, compared with a single vac-
cine. The most interesting but not yet explained is
the difference in the level of immune response when
a combination of the KHV vaccine and A. hydrophila
is applied. Although A. hydrophila helps increase KHV
antibody titers, its level is still higher than KHV. The
level of antibodies with the same or higher position
must be studied.
CONCLUSION
The combination vaccine of KHV: Aeromonas
hydrophila 1:2 and vaccine volume of 3 mL via oral
application is effective in decreasing mortality of koi
and common carp from KHV and A. hydrophila co-
infection. The combination vaccine simplifies the im-
munization schedule, which increase the overall health
of cultured fish, benefits fish farmers with lower cost
production and service extension officers.
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